共 39 条
- [1] Aller R, 2015, EUR REV MED PHARMACO, V19, P3118
- [4] The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1038 - 1048
- [5] Silymarin in non alcoholic fatty liver disease [J]. WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (03) : 109 - 113
- [6] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) : 811 - 826
- [7] Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
- [8] Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels [J]. MOLECULAR METABOLISM, 2014, 3 (05): : 565 - 580
- [10] Han H, 2021, FOOD FUNCT, V12, P2171, DOI [10.1039/d0fo02623a, 10.1039/D0FO02623A]